Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clonal Transitions and Phenotypic Evolution in Barrett's Esophagus.
Evans JA, Carlotti E, Lin ML, Hackett RJ, Haughey MJ, Passman AM, Dunn L, Elia G, Porter RJ, McLean MH, Hughes F, ChinAleong J, Woodland P, Preston SL, Griffin SM, Lovat L, Rodriguez-Justo M, Huang W, Wright NA, Jansen M, McDonald SAC. Evans JA, et al. Among authors: porter rj. Gastroenterology. 2022 Apr;162(4):1197-1209.e13. doi: 10.1053/j.gastro.2021.12.271. Epub 2021 Dec 29. Gastroenterology. 2022. PMID: 34973296 Free PMC article.
Current concepts in tumour-derived organoids.
Porter RJ, Murray GI, McLean MH. Porter RJ, et al. Br J Cancer. 2020 Oct;123(8):1209-1218. doi: 10.1038/s41416-020-0993-5. Epub 2020 Jul 30. Br J Cancer. 2020. PMID: 32728094 Free PMC article. Review.
Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival.
Porter RJ, Murray GI, Hapca S, Hay A, Craig SG, Humphries MP, James JA, Salto-Tellez M, Brice DP, Berry SH, McLean MH. Porter RJ, et al. Cancers (Basel). 2023 Mar 20;15(6):1865. doi: 10.3390/cancers15061865. Cancers (Basel). 2023. PMID: 36980751 Free PMC article.
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma.
Baxter MA, Spender LC, Cairns D, Walsh S, Oparka R, Porter RJ, Bray S, Skinner G, King S, Turbitt J, Collinson D, Miedzybrodzka ZH, Jellema G, Logan G, Kennedy RD, Turkington RC, McLean MH, Swinson D, Grabsch HI, Lord S, Seymour MJ, Hall PS, Petty RD. Baxter MA, et al. Among authors: porter rj. ESMO Open. 2024 May;9(5):103450. doi: 10.1016/j.esmoop.2024.103450. Epub 2024 May 13. ESMO Open. 2024. PMID: 38744099 Free PMC article. Clinical Trial.
346 results